RxDoctor Payments DataLook up a doctor →

Vimpat: payments to doctors

Payments that named Vimpat as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$483K
Providers
3,942
Transactions
18,255
Average per transaction
$26

The per-transaction average — $26 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,942 providers the average total is $122, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
UCB, Inc.$400,85483.0%
UCB SA$65,20913.5%
UCB Biosciences Inc.$11,1692.3%
UCB GmbH$5,5961.2%
← All drugs & devices